An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.
Clinical trial NCT00750880 · COMPLETED
Trial details
- NCT number
- NCT00750880
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-07-01
- Enrollment
- 1681
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.